Schedule 13G ownership disclosure

CUE BIOPHARMA INC

Security class unavailable · CUSIP: 22978P106

Event date: 2024-02-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001781002-24-000025
Form type
SC 13G
Filer
Bleichroeder LP
CIK
CIK 1781002
Filed
Mar 11, 2024
Reporting period
Feb 27, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub